Gotowa bibliografia na temat „Hematology”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Hematology”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Hematology"
Clark, Sherrie G., i Natalie Coffer. "Normal Hematology and Hematologic Disorders in Potbellied Pigs". Veterinary Clinics of North America: Exotic Animal Practice 11, nr 3 (wrzesień 2008): 569–82. http://dx.doi.org/10.1016/j.cvex.2008.03.003.
Pełny tekst źródłaMay, Jori E., Patrick C. Irelan, Kailee Boedeker, Emily Cahill, Steven Fein, David A. Garcia, Lisa K. Hicks i in. "Systems-based hematology: highlighting successes and next steps". Blood Advances 4, nr 18 (22.09.2020): 4574–83. http://dx.doi.org/10.1182/bloodadvances.2020002947.
Pełny tekst źródłaTahmasebi, Houman, Victoria Higgins, Mary Kathryn Bohn, Alexandra Hall i Khosrow Adeli. "CALIPER Hematology Reference Standards (I)". American Journal of Clinical Pathology 154, nr 3 (20.06.2020): 330–41. http://dx.doi.org/10.1093/ajcp/aqaa059.
Pełny tekst źródłaPrabhat, Daksha, Tejaswini Waghmare i Tasneem Rangwala. "Utility of Hematology Histograms". Annals of Pathology and Laboratory Medicine 6, nr 5 (24.05.2019): A309–319. http://dx.doi.org/10.21276/apalm.2527.
Pełny tekst źródłaFrancis, J. L. "Hematology". Blood Coagulation & Fibrinolysis 2, nr 4 (sierpień 1991): 575. http://dx.doi.org/10.1097/00001721-199108000-00011.
Pełny tekst źródła&NA;. "Hematology". American Journal of Clinical Oncology 16, nr 2 (kwiecień 1993): 184. http://dx.doi.org/10.1097/00000421-199304000-00027.
Pełny tekst źródłaBeirne, O. Ross. "Hematology". Journal of Oral and Maxillofacial Surgery 66, nr 8 (sierpień 2008): 3. http://dx.doi.org/10.1016/j.joms.2008.05.016.
Pełny tekst źródłaMESSICK, J. "Hematology". Veterinary Clinics of North America: Small Animal Practice 33, nr 6 (listopad 2003): xiii. http://dx.doi.org/10.1016/s0195-5616(03)00124-4.
Pełny tekst źródłaManspeizer, Heather E. "Hematology". Journal of Cardiothoracic and Vascular Anesthesia 15, nr 2 (kwiecień 2001): 269. http://dx.doi.org/10.1016/s1053-0770(01)70009-2.
Pełny tekst źródłaMessick, Joanne B. "Hematology". Veterinary Clinics of North America: Small Animal Practice 42, nr 1 (styczeń 2012): xi—xii. http://dx.doi.org/10.1016/j.cvsm.2011.11.002.
Pełny tekst źródłaRozprawy doktorskie na temat "Hematology"
Linnér, Jonathan. "Flödescytometri : Metodverifiering av flödescytometri med immunologisk tillämpning". Thesis, Linnéuniversitetet, Institutionen för kemi och biomedicin (KOB), 2017. http://urn.kb.se/resolve?urn=urn:nbn:se:lnu:diva-64927.
Pełny tekst źródłaMagnin, Olivier. "Diffractive optics applied to hematology". Université Louis Pasteur (Strasbourg) (1971-2008), 2002. https://publication-theses.unistra.fr/public/theses_doctorat/2002/MAGNIN_Olivier_2002.pdf.
Pełny tekst źródłaThe topic of this thesis is blood cells characterization by optical methods. Throughout this work we propose to design and realize a diffractive beam shaper especially adapted to blood cells differentiation, the beam shaper will be next integrated in a blood cell analyzer. The proposed diffractive beam shaper is globally optimized taking into account specific constraints of flow cytometry optical measurements as well as constraints linked to diffractive optics design and fabrication. The proposed design will reduce misalignments sensitivity and enhance measurement accuracy at lower cost than standard optical setups. In order to set the context of the study we first introduce the required hematology and flow cytometry backgrounds. The rest of the work focuses on the proposed diffractive beam shaper synthesis: specifications, phase function determination, prototype fabrication and experimental validation. Prototypes of the proposed diffractive beam shaper have been realized. Those prototypes have first been tested and validated as stand alone optical components. They have next been integrated in the overall optical blood cells differentiation system. Experiments we have realized have proven that the proposed diffractive beam shaping function is especially adapted to optical blood cells characterization: alignment and tolerancing of one critical component have been relaxed and measurement stability has been enhanced
ORRU', FEDERICA. "Role of Telomeres in Onco-Hematology". Doctoral thesis, Università degli Studi di Cagliari, 2017. http://hdl.handle.net/11584/249705.
Pełny tekst źródłaDias, Dácio de Castro. "Hematologia e bioquímica sérica em muares". Universidade de São Paulo, 2014. http://www.teses.usp.br/teses/disponiveis/10/10136/tde-28072014-153256/.
Pełny tekst źródłaThe purpose of this study was to determine hematological and biochemical values of three age groups of mules and to compare them with the forming races. For the development of this study, it was used 288 animals, males or females, as follows: 10 donkeys, 30 mares and 260 mules. The mules were divided into three groups: G1 (animals between two months and one year old), G2 (animals between one and three years old) and G3 (animals above three years old). The following laboratory evaluations were performed: blood count, platelet count, fibrinogen, glucose, urea, creatinine, creatine kinase, aspartate aminotransferase, gamma glutamyl transferase, alkaline phosphatase, lactate dehydrogenase, bilirubin, total protein, albumin, triglycerides, cholesterol, lactate, sodium, chlorine, potassium, calcium, phosphorus, magnesium and iron. In addition to the establishment of reference values for blood count and serum biochemistry for mules of three age groups, it is also concluded that: hematologically, the mules are closer to donkeys than the horses; there is a significant difference in biochemical and haematological values between age groups; there is a sexual influence in the mules haematological and biochemical values, but it is clinically less significant than the age influence; the hemoparasite Theileria equi can be found in the blood smear in a significant number of mules, even if they do not show clinical symptoms.
Cruz, Nathan da Rocha Neves [UNESP]. "Influência da anemia ferropriva no eletroforetrograma de hemoglobina de leitões". Universidade Estadual Paulista (UNESP), 2016. http://hdl.handle.net/11449/138874.
Pełny tekst źródłaApproved for entry into archive by Juliano Benedito Ferreira (julianoferreira@reitoria.unesp.br) on 2016-05-25T18:00:38Z (GMT) No. of bitstreams: 1 cruz_nrn_me_jabo.pdf: 1407515 bytes, checksum: fedc8b43e90de16bd74b61d1621c28ad (MD5)
Made available in DSpace on 2016-05-25T18:00:38Z (GMT). No. of bitstreams: 1 cruz_nrn_me_jabo.pdf: 1407515 bytes, checksum: fedc8b43e90de16bd74b61d1621c28ad (MD5) Previous issue date: 2016-02-29
Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
A hemoglobina é uma proteína globular composta por fração protéica (cadeias de globina), fração heme onde ocorre a ligação do íon bivalente de ferro, sendo que, as globinas combinadas ajudam a tipificar as hemoglobina em Hb Adulta (Hb A), Fetal (Hb F) e Adulta 2 (Hb A2). Na deficiência de ferro, que pode culminar anemia por disfunção eritropoiética, prevalente em leitões e seres humanos, a hemoglobina pode ter alterações estruturais denominadas hemoglobinopatias. O estudo determinou a influência do ferro nos tipos de hemoglobina de leitões neonatos. Perante os resultados se verificou que hemoglobina do leitão tem corrida semelhante à humana, e nos animais que apresentaram anemia ferropriva não houve aparecimento do traçado Hb A2, que pode estar diminuída em casos de deficiência de ferro em seres humanos.
Hemoglobin is a globular protein consisting of the protein fraction (globin chains), heme fraction which is the binding of the bivalent iron ion, and the combined globin help classify the hemoglobin in Hb Adult (Hb A), Fetal (Hb F) and Adult 2 (Hb A2). The iron deficiency can predispose anemia by erythropoietic dysfunction, prevalent in pigs and humans and the hemoglobin may have structural changes denominated hemoglobinopathies. The study determined the influence of iron to the types of hemoglobin neonate pigs. On the results was found that the pig hemoglobin is similar to human in electrophoresis. The piglets showed deficiency anemia there was appearance of line Hb A2, which may be diminished in cases of iron deficiency in humans.
CNPq: 158890/2015-9
CNPq: 130399/2014-0
CAPES: 23028003201-2014-41
Cornacini, Fernando Henrique. "Interferência da variação sazonal de fatores ambientais no perfil hematológico e bioquímico metabólico de 'Chelonoidis carbonarius' /". São José do Rio Preto, 2020. http://hdl.handle.net/11449/192759.
Pełny tekst źródłaResumo: O “jabuti-piranga” (Chelonoidis carbonarius) é um jabuti brasileiro, amplamente distribuído entre os estados do Nordeste, ocorrendo em áreas de Cerrado e campo aberto, mas também presente em recintos de zoológicos e aquários, distribuídos por todo o território nacional. São animais ectotérmicos, cujo metabolismo e fisiologia são influenciados por condições ambientais (como temperatura, umidade relativa da atmosfera e luminosidade) em magnitudes superiores aos dos animais endotérmicos, como aves e mamíferos, por exemplo. O atual trabalho tem por objetivo avaliar como esses fatores ambientais influenciam no perfil hematológico e bioquímico de “jabuti-pirangas” em cativeiro durante o período de um ano. Foi observado que machos e fêmeas diferiram no perfil hematológico, em que os primeiros apresentaram maiores valores para hematócrito, hemoglobina e eritrócito; enquanto que no perfil bioquímico, machos obtiveram maiores valores para glicose e as fêmeas para colesterol e triglicérides. Entre os meses do ano, foi possível observar menores valores para concentração de hemoglobina circulante e correspondentes índices hematimétricos nos meses de outubro e dezembro; enquanto que a concentração de colesterol e triglicérides teve aumento significativo em dezembro e junho, para machos e apenas em dezembro, para as fêmeas. Foi possível concluir que: a variação sazonal dos fatores ambientais influencia diretamente nos parâmetros hematológicos, reduzindo a concentração de hemoglobinas circul... (Resumo completo, clicar acesso eletrônico abaixo)
Abstract: The “red-footed tortoise” (Chelonoidis carbonarius) is a Brazilian tortoise, widely distributed among the states of the Northeast, occurring in areas of Cerrado and open fields, but also present in enclosures of zoos and aquariums, distributed throughout the national territory. They are ectotermal animals, whose metabolism and physiology are more influenced by environmental conditions (such as temperature, relative humidity and luminosity) than they are in endothermic animals, such as birds and mammals, for example. The aim of the current study is to evaluate how these environmental factors influence the hematological and biochemical profile of “redfooted tortoises” in captivity during the period of one year. It has been observed that males and females differed in the hematological profile, in which the former had higher values for hematocrit, hemoglobin and erythrocyte; whereas in the biochemical profile, males obtained higher values for glucose and females for cholesterol and triglycerides. Between the months of the year, it was possible to observe lower values for circulating hemoglobin concentration and corresponding hematimetric indices in the months of October and December; while the concentration of cholesterol and triglycerides increased significantly in December and June, in males and only in December, in females. It was possible to conclude the following: the seasonal variation of the environmental factors directly influences the hematological parameters, reducing t... (Complete abstract click electronic access below)
Mestre
Bistué, Rovira Àngel. "Potencial ús de la curcumina en el tractament de la Leucèmia Limfocítica Crònica". Doctoral thesis, Universitat Autònoma de Barcelona, 2020. http://hdl.handle.net/10803/671047.
Pełny tekst źródłaLa curcumina es un compuesto fenólico presente en el rizoma de la Curcuma longa, que ha sido estudiado en varios modelos de cáncer, por sus propiedades proapoptóticas, antiinflamatorias y quimiosensibilizadoras, entre otras. Sus efectos como inhibidor enzimático en múltiples vías metabólicas relacionadas con la progresión del cáncer la hacen un compuesto muy selectivo, con actividad antineoplásica a la vez que presenta una muy baja toxicidad. La Leucemia Linfocítica Crónica (LLC) es una enfermedad hematológica de elevada incidencia en países occidentales, originada por una expansión patológica de las células B, debido a unas tasas de apoptosis reducidas. A pesar de que la proliferación de estas células suele ser menor que en otras neoplasias, son muy difíciles de erradicar completamente, y los pacientes suelen recaer con el tiempo. La progresión de la enfermedad hacia fases más avanzadas, que requieren tratamientos más complejos y frecuentes, afecta la calidad de vida de los pacientes y limita su esperanza de vida, por lo que resulta de elevado interés encontrar mejoras en las terapias que permitan, por una parte, reducir las dosis y los efectos adversos, y por otra, mejorar el tratamiento y retrasar la progresión. En esta Tesis Doctoral se ha estudiado el efecto de la curcumina sobre modelos celulares de LLC, y en cultivos primarios obtenidos a partir de sangre periférica de pacientes con LLC, a fin de valorar el potencial para inducir apoptosis sobre las células de esta leucemia. Los primeros análisis consistieron en medir sobre tres modelos celulares de LLC (I83, MEC1 y EHEB) el efecto sinérgico de la curcumina en combinación con varios fármacos proapoptóticos (camptotecina, colchicina), antineoplásicos (etopósido y citarabina) y utilizados en el tratamiento de la LLC (fludarabina). Se midió por citometría de flujo del efecto citotóxico producido en función de la pérdida de la integridad de la membrana celular y el bloqueo de la proliferación, así como los efectos sobre el ciclo celular. Además, se realizaron citocentrifugaciones de las muestras y se analizaron por microscopía óptica para evaluar los efectos producidos sobre la citomorfologia. El efecto sinérgico de la curcumina también se valoró sobre cultivos primarios derivados de sangre periférica de pacientes con LLC. En este caso, la curcumina fue combinada con varios fármacos utilizados en el tratamiento de la LLC: fludarabina, ibrutinib y rituximab. Mediante citometría de flujo, se identificó la población leucémica, y las subpoblaciones con características de célula madre, más primitivas y refractarias (mediante los niveles de actividad de la fosfatasa alcalina) y se midió el efecto de los diferentes tratamientos sobre las células. Finalmente, se evaluó el efecto modulador de la curcumina sobre varios mecanismos implicados en la apoptosis de las células y la refractariedad a los tratamientos. Así, se han evaluado los efectos sobre la producción de especies reactivas del oxígeno (ROS), sobre la extrusión de fármacos y sobre la actividad caspasa. La curcumina mostró un efecto sinérgico variable en combinación con los fármacos testados, tanto en modelos celulares como en cultivos primarios, y produjo un aumento de la citotoxicidad, un bloqueo del ciclo celular y una reducción de los porcentajes de células con características de célula madre leucémica. Además, la curcumina mostró actividad en ciertos casos modulando la producción de ROS, la capacidad de extrusión de fármacos y generando la activación de las caspasas. Los resultados obtenidos confirman el potencial proapoptótico y adyuvante de la curcumina y justifican la realización de nuevos estudios dirigidos a una potencial implementación de la curcumina en los tratamientos.
Curcumin is a phenolic compound present in the rhizome of Curcuma longa, which has been extensively studied in various cancer models, for its proapoptotic, anti-inflammatory and chemosensitizing properties, among others. Its effects as an enzyme inhibitor in multiple metabolic pathways related to cancer progression make it a very selective compound, with antineoplastic activity while presenting low toxicity. Chronic Lymphocytic Leukemia (CLL) is a high-incidence hematologic disease in Western countries, caused by a pathological expansion of B cells, due to reduced rates of apoptosis. Although the proliferation rates of these cells are usually lower than in other neoplasms, they are difficult to eradicate completely, and patients often relapse over time. The progression of the disease to more advanced stages, which require more complex and frequent treatments, results in a reduction of the quality of life of patients and limiting their life expectancy, so it is of great interest to improve therapies, which would allow, on the one hand, to reduce the doses and the adverse effects, and on the other hand, to improve the treatment and to delay the progression. This Doctoral Thesis has studied the effect of curcumin on cell models derived from CLL, as well as in primary cultures obtained from peripheral blood of patients with CLL, in order to assess the potential to induce apoptosis on the cells of this leukemia. The first analysis consisted on measuring on three cellular models of CLL (I83, Mec1 and EHEB) the synergistic effect of curcumin in combination with various proapoptotic drugs (camptothecin, colchicine), antineoplastics (etoposide and cytarabine) and used in treatment of CLL (fludarabine). Flow cytometry was used to measure the cytotoxic effect produced depending on the loss of cell membrane integrity and proliferation blockade, as well as effects on the cell cycle. In addition, cytocentrifugations of the samples were performed and analyzed by optical microscopy to evaluate the effects produced on cytomorphology. The synergistic effect of curcumin was also assessed on primary cultures derived from peripheral blood from patients with CLL. In this case, curcumin was combined with several drugs used in the treatment of CLL: fludarabine, ibrutinib, and rituximab. Leukemic population was identified by flow cytometry, as well as the subpopulations with more primitive and refractory stem cell characteristics (detected using alkaline phosphatase activity levels) and the effect of the different treatments on cells. Finally, the modulatory effect of curcumin on various mechanisms involved in cell apoptosis and refractoryness to treatments has been evaluated. Thus, the effects on reactive oxygen species (ROS) production, drug extrusion, and caspase activity have been evaluated. Curcumin showed a variable synergistic effect in combination with tested drugs, both in cell models and in primary cell cultures, and produced an increase in cytotoxicity, a blockage of the cell cycle and a reduction of cells with leukemic stem cell characteristics. In addition, curcumin showed activity in certain cases by modulating ROS production, drug extrusion capacity, and generating caspase activation. The results obtained confirm the proapoptotic and adjuvant potential of curcumin and justify the performance of new studies aimed at a potential implementation of curcumin in treatments.
Gomes, Monteiro Lopes Baptista Maria João. "Molecular mechanisms of apoptosis induced by dexamethasone in chronic lymphocytic leukemia". Doctoral thesis, Universitat de Barcelona, 2012. http://hdl.handle.net/10803/92558.
Pełny tekst źródłaLos glucocorticoides son frecuentemente incluidos en la quimioterapia administrada a pacientes con leucemia linfática crónica (LLC), pues son potentes inmunosupresores e inducen la apoptosis de las células de LLC. Los mecanismos moleculares por los cuales los glucocorticoides inducen la apoptosis de las células de LLC son en gran parte desconocidos. Las células LLC de grupos pronósticos definidos por el estado mutacional de los genes IGHV y por la expresión de ZAP70 parecen tener diferentes respuestas a los glucocorticoides. La hipótesis de esta tesis es que hay genes o proteínas expresados de forma diferente en los grupos pronósticos de pacientes con LLC que determinan los diferentes niveles de apoptosis inducidos por los glucocorticoides. La sensibilidad al glucocorticoide dexametasona, se determino ex vivo en 50 muestras de pacientes con LLC y se comparo en función del estado mutacional de los genes IGHV y/o de la expresión de ZAP70. También se compararan los perfiles de expresión génica (GEP) de casos seleccionados. Los niveles de expresión de los genes de interés se validaran por QRT-PCR. La respuesta a la dexametasona es superior en los casos de LLC con genes IGHV no mutados/alta expresión de ZAP70. Los niveles de inducción del gen proapoptótico BIM se correlacionan con el grado de muerte celular. Los diferentes niveles de apoptosis inducida por dexametasona en los grupos de LLC definidos por la expresión de ZAP70 se traducen diferentes GEP. Las diferencias entre los GEP de cada grupo fueran principalmente cuantitativas, los casos con alta expresión de ZAP70 muestran niveles más altos de inducción/represión génica que los casos con baja expresión. Se observo que los niveles basales de ARNm y proteína de FKBP5, una cochaperona del receptor de los glucocorticoides, se correlacionan con el grado de apoptosis inducida por la dexametasona y que los niveles de FKBP5 son más elevados en los casos con alta expresión de ZAP70. GILZ induce diferencialmente por la dexametasona, observándose mayores inducciones en los casos con alta expresión de ZAP70. La inducción de GILZ se correlaciona con la inducción de BIM y con la magnitud de la apoptosis.
Medeiros, Fernanda Peres. "Variação da ecogenicidade difusa em parênquima hepático homogêneo relacionada aos achados bioquímicos e hematológicos em cães /". Jaboticabal :, 2009. http://hdl.handle.net/11449/89047.
Pełny tekst źródłaBanca: Áureo Evangelista Santana
Banca: Georgea Bignardi Jarretta
Resumo: No presente estudo foi analisado o parênquima hepático com características homogêneas e ecogenicidade difusa reduzida (G1), aumentada (G2) e normal (G3), em relação ao perfil dos animais, dimensão do fígado e achado bioquímico e hematológico. Amostras de sangue obtidas por punção venosa da jugular ou da cefálica do antebraço foram encaminhadas para realização de hemograma e dosagem sérica de ALT, FA, proteínas totais, albumina, globulina, uréia e creatinina. Dos 30 cães que compuseram o G1, 30 (100%) apresentaram evidência das paredes portais e da vesícula biliar, 23 (76,67%) fígado com dimensão preservada e bordos em ângulos agudos, 15 (50%) faixa etária entre 1 e 6 anos de idade e 8 (26,67%) eram da raça lhasa apso. Não houve predisposição quanto ao sexo, assim como não foram identificadas alterações significativas nos exames bioquímicos e hematológicos dos cães do G1. Quanto aos diagnósticos clínicos atribuídos para estes cães, houve maior prevalência de gastrinterite (43,33%). Dos 30 cães do G2, 27 animais (90%) apresentaram hepatomegalia e arredondamento dos bordos hepáticos, 18 (60%) tinham idade superior a 9 anos, 16 (53,33%) eram fêmeas e 9 (30%) eram da raça poodle. Houve elevação da atividade sérica de FA e elevação de ALT, redução nos níveis de proteínas séricas totais, albumina, globulinas, eritrócitos e volume globular, além de leucocitose por neutrofilia, com desvio à esquerda, eosinopenia, linfopenia e monocitose nos cães do G2. Neste grupo houve prevalência de doenças metabólicas (54%), como diabetes mellitus e hiperadrenocorticismo, além das hepatopatias crônicas (17%), atribuídas ao uso contínuo e prolongado de corticóide e drogas anticonvulsivantes. Dos 30 cães do grupo controle (G3), 22 (73,33%) apresentaram... (Resumo completo, clicar acesso eletrônico abaixo)
Abstract: The present study evaluated the liver with homogeneous parenchyma in dogs, with diffuse reduced echogenicity (G1), increased echogenicity (G2) and normal echogenicity (G3) by ultrasound examination associating the findings on animal profile, liver size and hematology and biochemistry results. Blood samples obtained by cephalic or jugular venipunture were submitted for hemogram and ALT, ALP, total proteins, albumin, globulin, urea and creatinine analysis. Among the 30 dogs in G1, 30 (100%) presented portal venous and gall bladder wall clarity, 23 (76.67%) presented normal liver size and edges, 15 (50%) were from 1 to 6 years old and 8 (26.67%) belonged to the lhasa apso breed. No predispositions were found according to gender, as well as no significant alterations in biochemical and hematological exams were observed in G1. The most prevalent disease found in this group was gastroenteritis (43.33%). Among the 30 dogs in G2, 27 (90%) presented hepatomegaly and rounded hepatic edges, 18 (60%) were over 9 years old, 16 (53.33%) were female and 9 (30%) belonged to the poodle breed. The laboratorial findings related to this group were increased ALT and ALP serum activity, decreased levels of total protein, albumin, globulin, erythrocytes and hematocrit, as well as leukocytosis with neutrophilia and a left shift, eosinopenia, lymphopenia and monocytosis. The most prevalent diseases found in this group were metabolic disorders (54%), such as diabetes mellitus and hyperadrenocorticism, and chronic hepatopathies (17%) due to prolonged and continuous use of corticoid and anticonvulsive drugs. Among the 30 dogs in the control group (G3), normal liver size and edges were presented in 22 (73.33%). In this group, no alterations were seen in laboratorial exams.
Mestre
Mendonça, Adriane Jorge. "Avaliação hematológica, bioquímica e hemostática de bezerros Brahman provenientes de produção in vitro (PIV) e bezerros Brahman de produção in vivo /". Botucatu, 2007. http://hdl.handle.net/11449/101311.
Pełny tekst źródłaBanca: Raimundo Souza Lopes
Banca: Alexandre Secorun Borges
Banca: Graziela Barioni
Banca: Mara Regina Stipp Balarin
Resumo: Avaliou-se alterações na hematologia, bioquímica e hemostasia de 112 bezerros Brahman produzidos in vitro (PIV) comparados a 20 bezerros Brahman produzidos in vivo, bem como avaliou-se a influência dos fatores etários e sexuais sobre os mesmos exames laboratoriais nos bezerros PIV em segundo estudo. Para tanto, os 112 bezerros PIV foram divididos em 4 grupos: 0-15 dias, 16-40 dias, 60-80 dias e 81-100 dias de idade com subdivisões para sexo em cada grupo. Todos foram submetidos aos exames de hemograma, às avaliações bioquímicas da uréia, creatinina, das proteínas totais séricas (PTS), albumina e globulina e da atividade sérica das enzimas aspartato amino transferase (AST) e creatina cinase (CK). A hemostasia foi avaliada pela determinação do tempo de protrombina (TP), tempo de tromboplastina parcial ativada (TTPA) e concentração do fibrinogênio. Analisando os resultados, concluiu-se que houve influência da produção in vitro nos valores bioquímicos do soro de bezerros Brahman manifestados por aumento das globulinas e diminuição da albumina em animais PIV; o fator etário influenciou na variação dos parâmetros analisados, refletidos por diminuição de neutrófilos segmentados, monócitos, uréia, CK, PTS, globulinas e fibrinogênio, e por aumento dos linfócitos e da creatinina com o avanço da idade. Machos tem valores médios de linfócitos (grupos de 0-15 e 60-80 dias de idade) e leucócitos totais (grupo de 60-80 dias) superiores às fêmeas. Fêmeas tem valores médios de monócitos (grupos de 16-40 e 60-80 dias) e de CK (grupo de 16-40 dias de idade) superiores aos machos
Abstract: Changes on hematology, biochemistry and hemostasis were evaluated in 112 Brahman's calves derived from in vitro-produced embryos (IVP) compared with 20 Brahman's calves derived from in vivo production. Age and sexual influences were evaluated on 112 IVP Brahman's calves divided in four groups: 0-15, 16-40, 60-80 and 81-100 days of age; each group were further subdivided according to their gender. All calves were submitted to the following laboratory tests: hemogram, urea, creatinine, total serum proteins (TSP), albumin and globulin levels and the serum activities of aspartate aminotransferase (AST) and creatine kinase (CK). The hemostasis was evaluated by the prothrombim time (PT), activated partial thromboplastin time (aPTT) and fibrinogen concentration. According to the results, it was concluded that albumin and globulin were influenced by the IVP, characterized by an increase in globulin and a decrease in albumin in IVP animals. Age have influenced the variation on the parameters analyzed, characterized by a decrease in the segmented neutrophils, monocytes, urea, CK, TSP, albumin and fibrinogen concentrations, and a creatinine increase with the age advance. Males has higher lymphocytes (groups of 0-15 and 60-80 days of age) and leukocytes (group of 60-80 days of age) values than females. Females has higher monocytes (groups 16-40 and 60-80 days of age) and CK (group of 16-40 days of age) values than males
Doutor
Książki na temat "Hematology"
Wintrobe, Maxwell Myer. Clinical hematology. [s.l: s.n.], 1987.
Znajdź pełny tekst źródła1901-, Wintrobe Maxwell Myer, i Lee G. Richard, red. Wintrobe's clinical hematology. Baltimore: Williams & Wilkins, 1999.
Znajdź pełny tekst źródła1901-, Wintrobe Maxwell Myer, i Greer John P. MD, red. Wintrobe's clinical hematology. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins Health, 2009.
Znajdź pełny tekst źródła1901-, Wintrobe Maxwell Myer, i Greer John P, red. Wintrobe's clinical hematology. Philadelphia: Lippincott Williams & Wilkins, 2004.
Znajdź pełny tekst źródła1923-, Beck William Samson, red. Hematology. Wyd. 4. Cambridge, Mass: MIT Press, 1985.
Znajdź pełny tekst źródłaS, Beck William, red. Hematology. Wyd. 4. Cambridge, Mass: MIT Press, 1985.
Znajdź pełny tekst źródłaErnest, Beutler, i Williams William J, red. Williams hematology. Wyd. 5. New York: McGraw-Hill, 1995.
Znajdź pełny tekst źródłaBeck, William S., red. Hematology. Cambridge: MIT Press, 1985.
Znajdź pełny tekst źródłaMcKenzie, Shirlyn B. Textbook of hematology. Wyd. 2. Baltimore: Williams & Wilkins, 1996.
Znajdź pełny tekst źródła1928-, Beutler Ernest, i Williams William J. 1926-, red. Williams hematology. Wyd. 6. New York: McGraw-Hill, Health Professions Division, 2001.
Znajdź pełny tekst źródłaCzęści książek na temat "Hematology"
Lee, Melinda A., i John R. Walsh. "Hematology". W Geriatric Medicine, 330–46. New York, NY: Springer New York, 1990. http://dx.doi.org/10.1007/978-1-4757-2093-8_26.
Pełny tekst źródłaAllen, Brandon, Latha Ganti i Bobby Desai. "Hematology". W Quick Hits in Emergency Medicine, 87–88. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-7037-3_14.
Pełny tekst źródłaStewart, Jill. "Hematology". W Oklahoma Notes, 193–227. New York, NY: Springer New York, 1996. http://dx.doi.org/10.1007/978-1-4612-4006-8_11.
Pełny tekst źródłaHirsch, Jeffrey G. "Hematology". W Oklahoma Notes, 237–60. New York, NY: Springer New York, 1996. http://dx.doi.org/10.1007/978-1-4612-4010-5_14.
Pełny tekst źródłaHui, David. "Hematology". W Approach to Internal Medicine, 143–84. Boston, MA: Springer US, 2010. http://dx.doi.org/10.1007/978-1-4419-6505-9_6.
Pełny tekst źródłaSherazi, Mubashar Hussain. "Hematology". W The Objective Structured Clinical Examination Review, 411–27. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-95444-8_14.
Pełny tekst źródłaFaye, Bernard, i Mohammed Bengoumi. "Hematology". W Camel Clinical Biochemistry and Hematology, 13–45. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-95562-9_2.
Pełny tekst źródłaMacNeill, Amy L. "Hematology". W Clinical Pathology and Laboratory Techniques for Veterinary Technicians, 19–74. Chichester, UK: John Wiley & Sons, Ltd, 2017. http://dx.doi.org/10.1002/9781119421351.ch2.
Pełny tekst źródłaJarolim, Dala R. "Hematology". W Oklahoma Notes, 174–200. New York, NY: Springer US, 1993. http://dx.doi.org/10.1007/978-1-4684-0458-6_9.
Pełny tekst źródłaHirsch, Jeffrey G. "Hematology". W Oklahoma Notes, 214–27. New York, NY: Springer US, 1994. http://dx.doi.org/10.1007/978-1-4684-0476-0_14.
Pełny tekst źródłaStreszczenia konferencji na temat "Hematology"
Astuti, Dewi, Eva Ayu Maharani i Fitri Zakiyah. "The Comparison of Routine Hematology Test Between Veins and Capillary Blood: Studies on Hematology Analyzer". W Proceedings of the 5th International Conference on Health Sciences (ICHS 2018). Paris, France: Atlantis Press, 2019. http://dx.doi.org/10.2991/ichs-18.2019.10.
Pełny tekst źródłaNitsch, Thorsten, Julia Lanznaster i Thomas Südhoff. "Ultrasound guided biopsy in hematology and oncology". W 46. Dreiländertreffen der DEGUM in Zusammenarbeit mit ÖGUM & SGUM. Georg Thieme Verlag, 2023. http://dx.doi.org/10.1055/s-0043-1772355.
Pełny tekst źródłaSullivan, Stephanie M., Brian G. Jamieson i Bradley E. Layton. "A Micro-Fabricated Electrical Impedance Based Hematology Analyzer". W ASME 2005 International Mechanical Engineering Congress and Exposition. ASMEDC, 2005. http://dx.doi.org/10.1115/imece2005-79446.
Pełny tekst źródłaBevilacqua, Vitoantonio, Domenico Buongiorno, Pierluigi Carlucci, Ferdinando Giglio, Giacomo Tattoli, Attilio Guarini, Nicola Sgherza i in. "A supervised CAD to support telemedicine in hematology". W 2015 International Joint Conference on Neural Networks (IJCNN). IEEE, 2015. http://dx.doi.org/10.1109/ijcnn.2015.7280464.
Pełny tekst źródłaHayden, Oliver. "Hematology analysis with holographic imaging cytometry (Conference Presentation)". W Quantitative Phase Imaging V, redaktorzy Gabriel Popescu i YongKeun Park. SPIE, 2019. http://dx.doi.org/10.1117/12.2513270.
Pełny tekst źródłaPizzi, Nicolino J., Sandhya Kapoor i Jon M. Gerrard. "Hematology Expert System (HES) For Tonsillectomy/Adenoidectomy Patients". W SPIE 1989 Technical Symposium on Aerospace Sensing, redaktor Mohan M. Trivedi. SPIE, 1989. http://dx.doi.org/10.1117/12.969339.
Pełny tekst źródłaColella, G. M., D. H. Tycko i W. Groner. "Technicon H*1 Hematology System: Optical Design Considerations". W 1988 Los Angeles Symposium--O-E/LASE '88, redaktorzy Kazuhiko Atsumi i Stephen N. Joffe. SPIE, 1988. http://dx.doi.org/10.1117/12.945330.
Pełny tekst źródłaYoung, Carole, i Jai Navlakha. "Expert Assistant For A Clinical Hematology Blood Cell Analyzer". W SPIE 1989 Technical Symposium on Aerospace Sensing, redaktor Mohan M. Trivedi. SPIE, 1989. http://dx.doi.org/10.1117/12.969340.
Pełny tekst źródłaLayton, Bradley E., Brian G. Jamieson i Stephanie M. Sullivan. "A Micro-Fabricated Electrical-Impedance-Based In-Flight Hematology Analyzer". W ASME 3rd International Conference on Microchannels and Minichannels. ASMEDC, 2005. http://dx.doi.org/10.1115/icmm2005-75219.
Pełny tekst źródłaLou, Rachel, i Thanh Le. "A Linear, Pixel-specific Color Normalization Algorithm for Hematology Imaging". W 8th International Conference on Bioimaging. SCITEPRESS - Science and Technology Publications, 2021. http://dx.doi.org/10.5220/0010344300002865.
Pełny tekst źródłaRaporty organizacyjne na temat "Hematology"
Lin, Zhijuan, Xing Chen, Long Liu, Zhifeng Li i Bing Xu. Chemo-Free Treatments in Relapsed and/or Refractory Follicular Lymphoma: A Network Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, listopad 2021. http://dx.doi.org/10.37766/inplasy2021.11.0111.
Pełny tekst źródłaVakhlova, I. V., i Yu N. Ibragimova. Electronic educational resource (EOR) "Hematology: Iron deficiency anemia in children". SIB-Expertise, luty 2023. http://dx.doi.org/10.12731/er0673.21022023.
Pełny tekst źródłaCorinna Hazelrig, Corinna Hazelrig. Assessing snake health in the southeastern United States through pathogen surveillance and hematology. Experiment, kwiecień 2022. http://dx.doi.org/10.18258/26187.
Pełny tekst źródłaShen, Meixiao, Juan Wang, Meiqing Lei i Zhiming Wang. The clinical characteristics and outcome of mucormycosis among patients with hematology diseases: a systematic and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, lipiec 2023. http://dx.doi.org/10.37766/inplasy2023.7.0069.
Pełny tekst źródłaPress, O. W. Improved radioimmunotherapy of hematologic malignancies. Office of Scientific and Technical Information (OSTI), marzec 1992. http://dx.doi.org/10.2172/5376292.
Pełny tekst źródłaPress, O. W. Improved radioimmunotherapy of hematologic malignancies. [Final report]. Office of Scientific and Technical Information (OSTI), marzec 1992. http://dx.doi.org/10.2172/10141667.
Pełny tekst źródłaPress, O. W. Improved radioimmunotherapy of hematologic malignancies. Final technical report. Office of Scientific and Technical Information (OSTI), sierpień 1996. http://dx.doi.org/10.2172/373849.
Pełny tekst źródłaPress, O. W., i D. F. Barofsky. Improved radioimmunotherapy of hematologic malignancies. Progress report, 1988--1991. Office of Scientific and Technical Information (OSTI), grudzień 1991. http://dx.doi.org/10.2172/10112383.
Pełny tekst źródłaBunner, David L., Harold A. Neufeld, Lucas H. Brennecke, Yvette G. Campbell i Richard E. Dinterman. Clinical and Hematologic Effects of T-2 Toxin in Rats. Fort Belvoir, VA: Defense Technical Information Center, sierpień 1985. http://dx.doi.org/10.21236/ada158874.
Pełny tekst źródłaBeidleman, Beth A., Janet E. Staab, Stephen R. Muza i Michael N. Sawka. Predicted Hematologic and Plasma Volume Responses Following Rapid Ascent to Progressive Altitudes. Fort Belvoir, VA: Defense Technical Information Center, czerwiec 2014. http://dx.doi.org/10.21236/ada614246.
Pełny tekst źródła